| Financial Year |
March 31 2023 |
| Monetary Funds |
27,663,352,328.96 |
| Held-for-trading Financial Assets |
380,949.10 |
| Notes Receivable |
73,426,895.36 |
| Accounts Receivable |
3,116,867,309.55 |
| Advances to Suppliers |
364,945,857.43 |
| Other Receivables |
1,063,760,260.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
14,089,344.75 |
| Inventories |
11,494,048,727.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
442,772,534.06 |
| Other Current Assets |
2,793,893,804.22 |
| Total Current Assets |
47,048,545,279.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
110,690,550.32 |
| Long-term Equity Investment |
72,592,704,694.71 |
| Investment Properties |
2,001,947,337.57 |
| Fixed Assetes |
32,435,464,183.77 |
| Under-construction Projects |
4,441,930,321.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
13,427,692,509.21 |
| R&D expenses |
-- |
| Goodwill |
251,321,924.03 |
| Long-Term Deferred and Prepaid Expenses |
4,325,814,812.91 |
| Deferred Income Tax Assets |
1,742,239,591.02 |
| Other Non-Current Assets |
1,028,869,318.07 |
| Sub-Total of Non-Current Assets |
137,023,815,160.41 |
| Total Assets |
184,072,360,440.20 |
| Short-Term Loans |
179,113,736.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
4,961,444,550.25 |
| Accounts Received In Advance |
132,819,184.13 |
| Employee Compensation Payable |
1,843,435,362.00 |
| Taxes Payable |
1,447,046,977.50 |
| Interest Payable |
-- |
| Dividend Payable |
90,580,642.02 |
| Other payables |
2,065,878,427.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,986,988,092.73 |
| Other Current Liabilities |
63,149,688.60 |
| Sub-Total of Current Liabilities |
19,622,185,210.74 |
| Long-term Loans |
19,523,452,915.41 |
| Bonds Payable |
17,182,528,579.53 |
| Long-Term Accounts Payable |
610,076,310.82 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,869,312.06 |
| Deferred Income Tax Liabilities |
840,967,869.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
39,649,486,186.79 |
| Total Liabilities |
59,271,671,397.53 |
| Paid-In Capital(Or Share Stock) |
23,284,144,750.00 |
| Capital Surplus |
11,275,529,419.21 |
| Surplus Reserve |
9,757,336,442.20 |
| LESS:Treasury Stock |
228,227,881.00 |
| Undistributed Profits |
71,317,642,886.36 |
| Minority Stockholder's Interest |
8,970,716,887.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
115,829,972,155.36 |
| Owner's Equity（Stockholder's Equity） |
124,800,689,042.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
184,072,360,440.20 |
